Genital inflammation, immune activation and risk of sexual HIV acquisition

Abstract

Purpose:

Women who have genital inflammation are at increased risk of sexual HIV infection. The purpose of this review is to evaluate the mechanisms for this relationship, causes of genital inflammation and strategies to manage this condition.

Recent Findings:

We have recently shown in a cohort of South African women that HIV seroconversion was associated with persistently raised genital inflammatory cytokines (including MIP-1α, MIP-1β and IP-10). Elevated inflammatory cytokine concentrations may facilitate HIV infection by recruiting and activating HIV target cells and disrupting the mucosal epithelial barrier. BV and STIs, which are predominantly asymptomatic in women, cause lower genital tract inflammation and increased HIV acquisition risk. In Africa, where syndromic management of STIs and BV is standard-of-care, the substantial burden of asymptomatic infections has likely contributed to high HIV incidence rates.

Summary:

A genital inflammatory profile contributes to the high risk of HIV acquisition in African women. STIs and BV are poorly managed in Africa and other developing nations and as such remain major drivers of persistent genital inflammation and HIV acquisition among these women.